Product image of Levetiracetam Doc (Levetiracetam) supplied by GNH India

Levetiracetam Doc

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Doc (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Doc, is an anticonvulsant presented as an oral formulation for oral use. It is employed to treat various seizure types in patients with epilepsy, including partial, generalized tonic‑clonic, and myoclonic seizures, and is marketed throughout the European Union.

GNH India supplies Levetiracetam Doc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance for global distribution. The company adheres to EU GMP standards.

Manufacturer / TM Owner

Doc Generici S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levetiracetam is an antiepileptic drug that reduces seizure activity across several seizure types.

  • Partial seizures: helps control focal onset seizures, reducing frequency and severity.
  • Generalized tonic-clonic seizures: provides seizure control for bilateral convulsive episodes.
  • Myoclonic seizures: diminishes rapid, brief muscle jerks associated with myoclonic epilepsy.

How It Works

  • Levetiracetam binds to the synaptic vesicle protein SV2A, a key regulator of neurotransmitter release. This interaction modulates synaptic vesicle exocytosis, stabilizing neuronal firing and decreasing hyper‑excitability. By influencing calcium‑dependent release of glutamate and other excitatory neurotransmitters, levetiracetam reduces the likelihood of abnormal electrical discharges that precipitate seizures.

Side Effects

Levetiracetam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Fatigue: feeling unusually tired or weak.
  • Headache: mild to moderate cranial pain.
  • Nausea: upset stomach or urge to vomit.
  • Irritability: mood changes or increased agitation.

Serious or Rare Side Effects

  • Severe allergic reaction: rash, swelling, or difficulty breathing.
  • Mood disorders: depression, anxiety, or suicidal thoughts.
  • Hematologic abnormalities: low blood cell counts.
  • Hepatic dysfunction: elevated liver enzymes or jaundice.
  • Stevens‑Johnson syndrome: severe skin blistering.

Precautions & Warnings

When prescribing levetiracetam, clinicians should consider several precautionary measures to ensure patient safety.

  • Renal impairment: assess kidney function and adjust dose if necessary.
  • Hepatic impairment: monitor liver enzymes and consider dose modification.
  • Psychiatric symptoms: watch for mood changes, depression, or suicidal ideation.
  • Concomitant alcohol use: advise patients to avoid alcohol, which may increase CNS effects.
  • Pregnancy: discuss potential risks with the prescriber, as safety data are limited.
  • Store at ambient temperature: keep below 25 °C in the original container, protect from moisture.

Avoid Interactions

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Carbamazepine: induces metabolism, reducing levetiracetam plasma levels.
  • Phenytoin: enzyme induction may lower levetiracetam concentrations.
  • Phenobarbital: may decrease levetiracetam exposure through increased clearance.

Moderate Interactions (Monitor Closely)

  • CNS depressants (e.g., benzodiazepines): may enhance sedation or dizziness.
  • Alcohol: can potentiate central nervous system effects.
  • Oral contraceptives: levetiracetam may reduce hormonal efficacy, requiring alternative contraception.

Frequently Asked Questions

Levetiracetam Doc is used to treat epilepsy by controlling various seizure types, including partial (focal) seizures, generalized tonic‑clonic seizures, and myoclonic seizures. It helps reduce the frequency and severity of seizures in patients diagnosed with these conditions.

Levetiracetam works by binding to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This action stabilizes neuronal firing and lowers neuronal excitability, thereby decreasing the likelihood of abnormal electrical activity that leads to seizures.

The appropriate dose of levetiracetam is determined by the prescribing healthcare professional based on the individual’s age, weight, renal function, seizure type, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for levetiracetam during pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits and risks before prescribing to pregnant or nursing women, and patients should discuss any concerns with their prescriber.

To order Levetiracetam Doc, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam is often favored for its broad spectrum of activity, minimal drug‑enzyme interactions, and generally favorable tolerability profile compared with older agents such as carbamazepine or phenytoin. However, individual response varies, and selection should be based on seizure type, comorbidities, and patient‑specific factors.

Levetiracetam Doc should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Levetiracetam Doc is taken orally, usually with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.

Serious risks include severe allergic reactions (such as rash, swelling, or breathing difficulty), mood changes including depression or suicidal thoughts, and rare hematologic or hepatic abnormalities. Patients should seek immediate medical attention if any of these symptoms occur.

Levetiracetam is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting enzyme‑inducing antiepileptic drugs without appropriate monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT